Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 1637.33 | 21 / 21 | 100% | 48.78 | 504 / 504 |
| liver | 100% | 1107.54 | 226 / 226 | 100% | 26.26 | 406 / 406 |
| uterus | 100% | 1443.74 | 170 / 170 | 100% | 49.36 | 459 / 459 |
| esophagus | 100% | 1501.24 | 1444 / 1445 | 100% | 39.48 | 183 / 183 |
| skin | 100% | 2273.98 | 1809 / 1809 | 100% | 32.86 | 471 / 472 |
| kidney | 100% | 1550.58 | 89 / 89 | 100% | 32.51 | 899 / 901 |
| ovary | 100% | 1719.68 | 180 / 180 | 100% | 36.35 | 429 / 430 |
| pancreas | 100% | 1035.37 | 327 / 328 | 100% | 59.77 | 178 / 178 |
| thymus | 100% | 1797.04 | 652 / 653 | 100% | 41.30 | 604 / 605 |
| stomach | 100% | 1277.67 | 359 / 359 | 100% | 42.37 | 285 / 286 |
| intestine | 100% | 1576.78 | 966 / 966 | 100% | 47.97 | 525 / 527 |
| prostate | 100% | 1898.94 | 245 / 245 | 100% | 42.24 | 500 / 502 |
| lung | 100% | 2229.89 | 577 / 578 | 100% | 42.97 | 1152 / 1155 |
| breast | 100% | 1359.89 | 459 / 459 | 99% | 41.00 | 1112 / 1118 |
| adrenal gland | 100% | 1754.27 | 258 / 258 | 99% | 57.64 | 228 / 230 |
| brain | 99% | 1745.84 | 2615 / 2642 | 95% | 20.76 | 673 / 705 |
| eye | 0% | 0 | 0 / 0 | 100% | 27.66 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 47.05 | 29 / 29 |
| peripheral blood | 100% | 7711.53 | 929 / 929 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3000.57 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 46.77 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 22.61 | 1 / 1 |
| blood vessel | 100% | 1499.76 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1257.62 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 97% | 851.17 | 781 / 803 | 0% | 0 | 0 / 0 |
| heart | 94% | 857.40 | 813 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0016075 | Biological process | rRNA catabolic process |
| GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
| GO_0030262 | Biological process | apoptotic nuclear changes |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0019725 | Biological process | cellular homeostasis |
| GO_0006396 | Biological process | RNA processing |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0003677 | Molecular function | DNA binding |
| GO_0030159 | Molecular function | signaling receptor complex adaptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | DEDD2 |
| Protein name | Death effector domain containing 2 DNA-binding death effector domain-containing protein 2 (DED-containing protein FLAME-3) (FADD-like anti-apoptotic molecule 3) |
| Synonyms | FLAME3 PSEC0004 |
| Description | FUNCTION: May play a critical role in death receptor-induced apoptosis and may target CASP8 and CASP10 to the nucleus. May regulate degradation of intermediate filaments during apoptosis. May play a role in the general transcription machinery in the nucleus and might be an important regulator of the activity of GTF3C3. |
| Accessions | ENST00000336034.8 [Q8WXF8-2] ENST00000596251.6 [Q8WXF8-1] ENST00000595337.5 [Q8WXF8-1] M0QYK9 ENST00000598200.1 M0QXK7 ENST00000598727.5 Q8WXF8 |